This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Asante Solutions Appoints New CEO, VP Operations

SUNNYVALE, Calif., April 11, 2012 /PRNewswire/ -- Asante Solutions, Inc. (Asante), a medical device company focused on diabetes care, has strengthened its leadership team by adding David Thrower as president and chief executive officer, and Eric Steuben as vice president of operations. Former President and Chief Executive Officer Phil Hopper will remain as a special advisor and board member.

"We are pleased to bring David and Eric to Asante as we progress toward our U.S. launch of the Pearl Insulin Pump," said Pete McNerney, Asante's chairman of the board and a partner at venture capital firm Thomas, McNerney & Partners. "David is an accomplished CEO and a proven sales and marketing strategist, and Eric is an energetic leader with over 20 years of progressive achievements from hands-on engineering to executive management."

David Thrower held previous roles as chief executive officer of InSound Medical, a manufacturer of a disruptive hearing aid system that was acquired by Sonova Holding AG, and vice president of global sales and marketing at Align Technology, Inc., a global medical device company that pioneered the invisible orthodontics market. He earned his undergraduate degree in mathematical and computational sciences from Stanford University and his master's degree in business administration from the Harvard Business School.

"I have known David during his years of leadership at InSound Medical and as a peer CEO. His career and successes have been at the intersection of medical devices and consumer insight. He brings a unique perspective to the insulin pump category," said Rick Thompson, Asante board member and chief executive officer and president of Reshape Medical.

Eric Steuben has broad corporate experience ranging from high-growth startups to world-leading corporations and has specialized insight into the medical device industry. Eric led the manufacturing, engineering, and operations teams at Align Technology and MicroDental Laboratories. He started his career in engineering, marketing, regulatory affairs and quality assurance at Varian Medical, a medical device manufacturer focused on the treatment of cancer. He earned a bachelor of science degree in mechanical engineering and a master's degree in business administration from Santa Clara University.

About the Pearl Insulin PumpThe Pearl Insulin Pump's many user-friendly features are designed to make the Pearl an easy-to-use system for those on intensive insulin therapy. The pump features a unique modular product configuration that allows significantly lower pump therapy initiation costs through pay-as-you-pump pricing. It is the only insulin pump using pre-filled 300 unit insulin cartridges for use in pumps for up to seven days. More product details are available at www.asantesolutions.com.

About Asante Solutions, Inc.Based in the heart of Silicon Valley, Asante Solutions, Inc. is a privately-held medical device company developing simple solutions for diabetes. For more information, visit www.asantesolutions.com.

SOURCE Asante Solutions, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs